A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus
- 1 August 2021
- journal article
- review article
- Published by American Association for Laboratory Animal Science in Comparative Medicine
- Vol. 71 (4) , 271-284
Abstract
Often referred to as the silent killer, ovarian cancer is the most lethal gynecologic malignancy. This disease rarely shows any physical symptoms until late stages and no known biomarkers are available for early detection. Because ovarian cancer is rarely detected early, the physiology behind the initiation, progression, treatment, and prevention of this disease remains largely unclear. Over the past 2 decades, the laying hen has emerged as a model that naturally develops epithelial ovarian cancer that is both pathologically and histologically similar to that of the human form of the disease. Different molecular signatures found in human ovarian cancer have also been identified in chicken ovarian cancer including increased CA125 and elevated E-cadherin expression, among others. Chemoprevention studies conducted in this model have shown that decreased ovulation and inflammation are associated with decreased incidence of ovarian cancer development. The purpose of this article is to review the major studies performed in laying hen model of ovarian cancer and discuss how these studies shape our current understanding of the pathophysiology, prevention, and treatment of epithelial ovarian cancer.Keywords
This publication has 100 references indexed in Scilit:
- Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTcBreast Cancer Research and Treatment, 2005
- Cyclooxygenases, peroxide tone and the allure of fish oilCurrent Opinion in Cell Biology, 2005
- Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolutionNature, 2004
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Gonadotropin-Releasing Hormone Agonist Suppression of Ovarian Tumorigenesis in Mice of the Wx/wv Genotype1Biology of Reproduction, 1995
- Clinical evaluations of a new ovarian cancer marker, COX‐1International Journal of Gynecology & Obstetrics, 1995
- Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: Direct and indirect actionsLife Sciences, 1995
- Prostaglandin and Thromboxane Production in Ovarian Cancer TissueGynecologic and Obstetric Investigation, 1984
- Prostacyclin and thromboxane in ovarian cancer: Effect of cytostatics and prostaglandin synthesis inhibitorsGynecologic Oncology, 1983
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983